+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Health Care Industry Forecasts - China Focus

  • PDF Icon

    Report

  • 124 Pages
  • May 2022
  • Region: China
  • AMID Co
  • ID: 3397822

China's demand for Health Care will continue to grow at about 11% by 2031

This study focuses on China’s Health Care industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumption in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumption of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.



Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.



This new study focuses on industry trends and forecasts with historical data (2011, 2016 and 2021) and long-term forecasts through 2026 and 2031 are presented.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases.



The author is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. They have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. The report provides hard-to-find market data and analyses. The publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.


Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS
  • Overview
  • Medical Treatment Revenues and Forecasts by Region
  • Northeast
  • Hospitals
  • Physicians
  • Hospital Visits
  • Medical Treatment Revenues
  • North
  • Hospitals
  • Physicians
  • Hospital Visits
  • Medical Treatment Revenues
  • Southeast
  • Hospitals
  • Physicians
  • Hospital Visits
  • Medical Treatment Revenues
  • Central South
  • Hospitals
  • Physicians
  • Hospital Visits
  • Medical Treatment Revenues
  • Southwest
  • Hospitals
  • Physicians
  • Hospital Visits
  • Medical Treatment Revenues
  • Northwest
  • Hospitals
  • Physicians
  • Hospital Visits
  • Medical Treatment Revenues
  • Medical Supplies Production and Demand
  • Major Producers
  • Total Output and Demand
  • Foreign Trade
  • Pricing Trends
  • Output and Demand by Region
  • Northeast
  • North
  • Southeast
  • Central South
  • Southwest
  • Northwest
  • Pharmaceuticals Production and Demand
  • Major Producers
  • Total Output and Demand
  • Foreign Trade
  • Pricing Trends
  • Output and Demand by Region
  • Northeast
  • North
  • Southeast
  • Central South
  • Southwest
  • Northwest
  • Medical Equipment Production and Demand
  • Major Producers
  • Total Output and Demand
  • Foreign Trade
  • Pricing Trends
  • Output and Demand by Region
  • Northeast
  • North
  • Southeast
  • Central South
  • Southwest
  • Northwest
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS
  • the Total Health Care Output and Demand
  • the Amount of Hospitals in Northeast
  • the Amount of Physicians in Northeast
  • the Amount of Hospital Visits in Northeast
  • the Medical Treatment Revenues in Northeast
  • the Amount of Hospitals in North
  • the Amount of Physicians in North
  • the Amount of Hospital Visits in North
  • the Medical Treatment Revenues in North
  • the Amount of Hospitals in Southeast
  • the Amount of Physicians in Southeast
  • the Amount of Hospital Visits in Southeast
  • the Medical Treatment Revenues in Southeast
  • the Amount of Hospitals in Central South
  • the Amount of Physicians in Central South
  • the Amount of Hospital Visits in Central South
  • the Medical Treatment Revenues in Central South
  • the Amount of Hospitals in Southwest
  • the Amount of Physicians in Southwest
  • the Amount of Hospital Visits in Southwest
  • the Medical Treatment Revenues in Southwest
  • the Amount of Hospitals in Northwest
  • the Amount of Physicians in Northwest
  • the Amount of Hospital Visits in Northwest
  • the Medical Treatment Revenues in Northwest
  • the Major Producers of Medical Supplies
  • the Total Medical Supplies Output and Demand
  • the Foreign Trade of Medical Supplies
  • the Medical Supplies Output and Demand in Northeast
  • the Medical Supplies Output and Demand in North
  • the Medical Supplies Output and Demand in Southeast
  • the Medical Supplies Output and Demand in Central South
  • the Medical Supplies Output and Demand in Southwest
  • the Medical Supplies Output and Demand in Northwest
  • the Major Producers of The Pharmaceuticals
  • the Pharmaceuticals Total Output and Demand
  • the Foreign Trade of the Pharmaceuticals
  • the Pharmaceuticals Output and Demand in Northeast
  • the Pharmaceuticals Output and Demand in North
  • the Pharmaceuticals Output and Demand in Southeast
  • the Pharmaceuticals Output and Demand in Central South
  • the Pharmaceuticals Output and Demand in Southwest
  • the Pharmaceuticals Output and Demand in Northwest
  • the Major Producers of Medical Equipments
  • the Medical Equipment Total Output and Demand
  • the Foreign Trade of the Medical Equipment
  • the Medical Equipment Output and Demand in Northeast
  • the Medical Equipment Output and Demand in North
  • the Medical Equipment Output and Demand in Southeast
  • the Medical Equipment Output and Demand in Central South
  • the Medical Equipment Output and Demand in Southwest
  • the Medical Equipment Output and Demand in Northwest
LIST OF CHARTS
I. INTRODUCTION
  • China’s Health Care Industry Output and Demand
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS
  • the Medical Goods Output and Demand
  • the Total Medical Supplies Output and Demand
  • the Pharmaceuticals Total Output and Demand
  • the Medical Equipment Total Output and Demand

Executive Summary



Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.

Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.